Low Dose Ketamine Infusion for the Treatment of Resistant Depression

The purpose of this investigator-initiated observational study is to examine how low ketamine infusion treatments impact antidepressant and anti-suicidal effects for refractory and non-refractory depression.

Topic Depression Treatment-Resistant Depression Suicidality
Compound Ketamine
Country United States of America
Visit trial
Status Withdrawn
Results Published No
Start date 29 June 2020
End date 29 December 2020
Phase Not Applicable
Design Open
Type Observational
Participants 0
Sex All
Age 18- 89
Therapy No

Trial Details

The purpose of this investigator-initiated observational study is to examine how low Ketamine infusion treatments impact antidepressant and anti-suicidal effects for refractory and non-refractory depression.

Trial Number NCT04283058

Sponsors & Collaborators

Loma Linda University
This company doesn't have a full profile yet, it is linked to a clinical trial.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.